| 注册
首页|期刊导航|临床肝胆病杂志|受控哀减参数评估脂肪性肝病的研究进展

受控哀减参数评估脂肪性肝病的研究进展

卢加发 范建高

临床肝胆病杂志Issue(5):806-809,4.
临床肝胆病杂志Issue(5):806-809,4.DOI:10.3969/j.issn.1001-5256.2015.05.044

受控哀减参数评估脂肪性肝病的研究进展

Research progress in controlled attenuation parameter for assessment of fatty liver disease

卢加发 1范建高1

作者信息

  • 1. 上海交通大学医学院附属新华医院 消化内科,上海 200092
  • 折叠

摘要

Abstract

Controlled attenuation parameter (CAP)is a noninvasive,quantitative,fast,and reliable novel tool for the assessment of fatty liver disease (FLD),and it has been a hotspot in the noninvasive diagnosis of FLD.This paper introduces factors associated with CAP asses-sing FLD,the cut -off value for the diagnosis of liver steatosis,and the causes of the failure of CAP measurement and unreliable CAP meas-urement.The paper believes that even though the noninvasive and quantitative diagnosis of FLD by CAP has been confirmed by many stud-ies,most of the results were obtained with a limited sample size.Therefore,the factors associated with the cut -off value for CAP diagnosing liver steatosis and factors influencing the measurement results still need validation with larger samples and multi -centered research reports.

关键词

脂肪肝/受控衰减参数/诊断/综述

Key words

fatty liver/controlled attenuation parameter/diagnosis/reviev

分类

医药卫生

引用本文复制引用

卢加发,范建高..受控哀减参数评估脂肪性肝病的研究进展[J].临床肝胆病杂志,2015,(5):806-809,4.

基金项目

国家科技部973项目 ()

临床肝胆病杂志

OACSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文